Back to mobile site

Form SCHEDULE 13G EKSO BIONICS HOLDINGS, Filed by: Kosow Keith

March 19, 2026 4:08 PM EDT





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
   Rule 13d-1(b)
   Rule 13d-1(c)
   Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person:  As more fully described in Item 4 of this Statement on Schedule 13G (this ''Schedule 13G''), such shares and percentage are based on 3,563,381 shares of common stock, par value $0.001 per share, of the issuer (the ''Common Stock'') outstanding as of February 20, 2026, as disclosed in the issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission on February 23, 2026 (the ''Form 10-K'').


SCHEDULE 13G




Comment for Type of Reporting Person:  As more fully described in Item 4 of this Schedule 13G, such shares and percentage are based on 3,563,381 shares of Common Stock outstanding as of February 20, 2026, as disclosed in the Form 10-K.


SCHEDULE 13G



 
Kosow Keith
 
Signature:/s/ Keith Kosow
Name/Title:Individual
Date:03/19/2026
 
Cedar Holdings Mgmt LLC
 
Signature:/s/ Keith Kosow
Name/Title:Authorized Signatory
Date:03/19/2026

Comments accompanying signature:  See Exhibit 1 filed herewith.

ATTACHMENTS / EXHIBITS

EX-1



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings

Related Entities

13G